![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » China to Exempt Imported Cancer Drugs From Tariffs
China to Exempt Imported Cancer Drugs From Tariffs
April 19, 2018
Under a new policy set to take effect May 1, China will exempt cancer drugs made overseas from import tariffs.
China’s State Council also pledged to reduce the value-added tax on such products to further ease financial pressures on patients.
Currently, the import tax for cancer drugs from the U.S. is 4 percent. The current value-added tax is 17 percent.
Upcoming Events
-
21Oct